Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print February 7, 2008, 10.1148/radiol.2471070711
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow All Versions of this Article:
2471070711v1
247/1/273    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soulez, G.
Right arrow Articles by Pirovano, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soulez, G.
Right arrow Articles by Pirovano, G.
(Radiology 2008;247:273-285.)
© RSNA, 2008

Vascular and Interventional Radiology

Renal Artery Stenosis Evaluation: Diagnostic Performance of Gadobenate Dimeglumine–enhanced MR Angiography—Comparison with DSA1

Gilles Soulez, MD, MSc, Mieczyslaw Pasowicz, MD, Giorgio Benea, MD, Luigi Grazioli, MD, Juan Pablo Niedmann, MD, Marek Konopka, MD, Philippe C. Douek, MD, Giovanni Morana, MD, Fritz K. W. Schaefer, MD, Angelo Vanzulli, MD, David A. Bluemke, MD, Jeffrey H. Maki, MD, Martin R. Prince, MD, PhD, Günther Schneider, MD, PhD, Claudio Ballarati, MD, Richard Coulden, MD, Martin N. Wasser, MD, Thomas R. McCauley, MD, Miles A. Kirchin, PhD, and Gianpaolo Pirovano, MD

1 From the Department of Radiology, Centre Hospitalier de l'Université de Montréal, University of Montreal, 1560 Sherbrooke East, Montreal, QC, Canada H2V 2Z2 (G. Soulez). The complete list of author affiliations and enrolling centers is at the end of this article. From the 2006 RSNA Annual Meeting. Received April 21, 2007; revision requested June 11; revision received July 20; accepted August 17; final version accepted September 26. Supported by Bracco Diagnostics and by research scholarships from the Fonds de la Recherche en Santé du Québec (G. Soulez). Address correspondence to G. Soulez (e-mail: gilles.soulez.chum{at}ssss.gouv.qc.ca).

Purpose: To prospectively determine diagnostic performance and safety of contrast material–enhanced (CE) magnetic resonance (MR) angiography with 0.1 mmol per kilogram of body weight gadobenate dimeglumine for depiction of significant steno-occlusive disease (≥51% stenosis) of renal arteries, with digital subtraction angiography (DSA) as reference standard.

Materials and Methods: This multicenter study was approved by local institutional review boards; all patients provided written informed consent. Patient enrollment and examination at centers in the United States complied with HIPAA. Two hundred ninety-three patients (154 men, 139 women; mean age, 61.0 years) with severe hypertension (82.2%), progressive renal failure (11.3%), and suspected renal artery stenosis (6.5%) underwent CE MR angiography with three-dimensional spoiled gradient-echo sequences after administration of 0.1 mmol/kg gadobenate dimeglumine at 2 mL/sec. Anteroposterior and oblique DSA was performed in 268 (91.5%) patients. Three independent blinded reviewers evaluated CE MR angiographic images. Sensitivity, specificity, and accuracy of CE MR angiography for detection of significant steno-occlusive disease (≥51% vessel lumen narrowing) were determined at segment (main renal artery) and patient levels. Positive and negative predictive values and positive and negative likelihood ratios were determined. Interobserver agreement was analyzed with generalized {kappa} statistics. A safety evaluation (clinical examination, electrocardiogram, blood and urine analysis, monitoring for adverse events) was performed.

Results: Of 268 patients, 178 who were evaluated with MR angiography and DSA had significant steno-occlusive disease of renal arteries at DSA. Sensitivity, specificity, and accuracy of CE MR angiography for detection of 51% or greater stenosis or occlusion were 60.1%–84.1%, 89.4%–94.7%, and 80.4%–86.9%, respectively, at segment level. Similar values were obtained for predictive values and for patient-level analyses. Few CE MR angiographic examinations (1.9%–2.8%) were technically inadequate. Interobserver agreement for detection of significant steno-occlusive disease was good (79.9% agreement; {kappa} = 0.69). No safety concerns were noted.

Conclusion: CE MR angiography performed with 0.1 mmol/kg gadobenate dimeglumine, compared with DSA, is safe and provides good sensitivity, specificity, and accuracy for detection of significant renal artery steno-occlusive disease.

Supplemental material: radiology.rsnajnls.org/cgi/content/full/2471070711/DC1

© RSNA, 2008




This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
S. H. Choi, J. M. Lee, N. C. Yu, K.-S. Suh, J.-J. Jang, S. H. Kim, and B. I. Choi
Hepatocellular Carcinoma in Liver Transplantation Candidates: Detection with Gadobenate Dimeglumine-Enhanced MRI
Am. J. Roentgenol., August 1, 2008; 191(2): 529 - 536.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2008 by the Radiological Society of North America.